Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cyclic peptides as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders

Cyclic peptides as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders

US Patent 12209144 · Granted Jan 28, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Metabolomic characterization of microorganisms2025
Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses ther2024
Compositions and methods for selective protein degradation2024
Rapid display method in translational synthesis of peptide2024
Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK2023
Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK2023
Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK2023
Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK2023
Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK2023
Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK2023
Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses ther2023
1,2,4-oxadiazole derivatives as liver X receptor agonists2022